Bipolar Disorder

Bipolar Disorder

Bipolar Disorder market worldwide is projected to grow by US$848.8 Million, driven by a compounded growth of 2.3%. Mood Stabilizers, one of the segments analyzed and sized in this study, displays the potential to grow at over 1.6%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$608.5 Million by the year 2025, Mood Stabilizers will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 1.9% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$34 Million to the region's size and clout in the next 5 to 6 years. Over US$24.7 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Mood Stabilizers will reach a market size of US$28.3 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 3.6% over the next couple of years and add approximately US$231.2 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include among others, AbbVie, Inc.; Allergan PLC; AstraZeneca PLC; Eli Lilly and Company; GlaxoSmithKline PLC; Janssen Pharmaceuticals; Novartis International AG; Otsuka Pharmaceutical Co., Ltd.; Pfizer, Inc.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Bipolar Disorder Competitor Market Share Scenario Worldwide (in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Bipolar Disorder Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 2: Bipolar Disorder Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
TABLE 3: Bipolar Disorder Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
TABLE 4: Mood Stabilizers (Drug Class) World Market by Region/Country in US$ Million: 2018 to 2025
TABLE 5: Mood Stabilizers (Drug Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
TABLE 6: Mood Stabilizers (Drug Class) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
TABLE 7: Anticonvulsants (Drug Class) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
TABLE 8: Anticonvulsants (Drug Class) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
TABLE 9: Anticonvulsants (Drug Class) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
TABLE 10: Antipsychotic Drugs (Drug Class) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
TABLE 11: Antipsychotic Drugs (Drug Class) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
TABLE 12: Antipsychotic Drugs (Drug Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
TABLE 13: Antidepressant Drugs (Drug Class) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
TABLE 14: Antidepressant Drugs (Drug Class) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
TABLE 15: Antidepressant Drugs (Drug Class) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
TABLE 16: Anti-anxiety Drugs (Drug Class) World Market by Region/Country in US$ Million: 2018 to 2025
TABLE 17: Anti-anxiety Drugs (Drug Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
TABLE 18: Anti-anxiety Drugs (Drug Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Bipolar Disorder Market Share (in %) by Company: 2019 & 2025
TABLE 19: United States Bipolar Disorder Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
TABLE 20: Bipolar Disorder Market in the United States by Drug Class: A Historic Review in US$ Million for 2009-2017
TABLE 21: United States Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
JAPAN
TABLE 22: Japanese Market for Bipolar Disorder: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
TABLE 23: Bipolar Disorder Market in Japan: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
TABLE 24: Japanese Bipolar Disorder Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
CANADA
TABLE 25: Canadian Bipolar Disorder Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
TABLE 26: Canadian Bipolar Disorder Historic Market Review by Drug Class in US$ Million: 2009-2017
TABLE 27: Bipolar Disorder Market in Canada: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
CHINA
TABLE 28: Chinese Bipolar Disorder Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
TABLE 29: Bipolar Disorder Historic Market Analysis in China in US$ Million by Drug Class: 2009-2017
TABLE 30: Chinese Bipolar Disorder Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
FRANCE
TABLE 31: Bipolar Disorder Market in France by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 32: French Bipolar Disorder Historic Market Scenario in US$ Million by Drug Class: 2009-2017
TABLE 33: French Bipolar Disorder Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
EUROPE
Market Facts & Figures
European Bipolar Disorder Market: Competitor Market Share Scenario (in %) for 2019 & 2025
TABLE 34: European Bipolar Disorder Market Demand Scenario in US$ Million by Region/Country: 2018-2025
TABLE 35: Bipolar Disorder Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
TABLE 36: European Bipolar Disorder Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
TABLE 37: European Bipolar Disorder Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
TABLE 38: Bipolar Disorder Market in Europe in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
TABLE 39: European Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
ITALY
TABLE 40: Italian Bipolar Disorder Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
TABLE 41: Bipolar Disorder Historic Market Analysis in Italy in US$ Million by Drug Class: 2009-2017
TABLE 42: Italian Bipolar Disorder Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
GERMANY
TABLE 43: Bipolar Disorder Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
TABLE 44: German Bipolar Disorder Historic Market Analysis in US$ Million by Drug Class: 2009-2017
TABLE 45: German Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
UNITED KINGDOM
TABLE 46: United Kingdom Market for Bipolar Disorder: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
TABLE 47: Bipolar Disorder Market in the United Kingdom: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
TABLE 48: United Kingdom Bipolar Disorder Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
SPAIN
TABLE 49: Spanish Bipolar Disorder Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
TABLE 50: Spanish Bipolar Disorder Historic Market Review by Drug Class in US$ Million: 2009-2017
TABLE 51: Bipolar Disorder Market in Spain: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
RUSSIA
TABLE 52: Russian Bipolar Disorder Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
TABLE 53: Bipolar Disorder Market in Russia by Drug Class: A Historic Review in US$ Million for 2009-2017
TABLE 54: Russian Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
REST OF EUROPE
TABLE 55: Rest of Europe Bipolar Disorder Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
TABLE 56: Bipolar Disorder Market in Rest of Europe in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
TABLE 57: Rest of Europe Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
ASIA-PACIFIC
TABLE 58: Asia-Pacific Bipolar Disorder Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 59: Bipolar Disorder Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
TABLE 60: Asia-Pacific Bipolar Disorder Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
TABLE 61: Bipolar Disorder Market in Asia-Pacific by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 62: Asia-Pacific Bipolar Disorder Historic Market Scenario in US$ Million by Drug Class: 2009-2017
TABLE 63: Asia-Pacific Bipolar Disorder Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
AUSTRALIA
TABLE 64: Bipolar Disorder Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
TABLE 65: Australian Bipolar Disorder Historic Market Analysis in US$ Million by Drug Class: 2009-2017
TABLE 66: Australian Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
INDIA
TABLE 67: Indian Bipolar Disorder Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
TABLE 68: Indian Bipolar Disorder Historic Market Review by Drug Class in US$ Million: 2009-2017
TABLE 69: Bipolar Disorder Market in India: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
SOUTH KOREA
TABLE 70: Bipolar Disorder Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
TABLE 71: South Korean Bipolar Disorder Historic Market Analysis in US$ Million by Drug Class: 2009-2017
TABLE 72: Bipolar Disorder Market Share Distribution in South Korea by Drug Class: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
TABLE 73: Rest of Asia-Pacific Market for Bipolar Disorder: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
TABLE 74: Bipolar Disorder Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
TABLE 75: Rest of Asia-Pacific Bipolar Disorder Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
LATIN AMERICA
TABLE 76: Latin American Bipolar Disorder Market Trends by Region/Country in US$ Million: 2018-2025
TABLE 77: Bipolar Disorder Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
TABLE 78: Latin American Bipolar Disorder Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
TABLE 79: Latin American Bipolar Disorder Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
TABLE 80: Bipolar Disorder Historic Market Analysis in Latin America in US$ Million by Drug Class: 2009-2017
TABLE 81: Latin American Bipolar Disorder Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
ARGENTINA
TABLE 82: Argentinean Bipolar Disorder Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
TABLE 83: Bipolar Disorder Market in Argentina in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
TABLE 84: Argentinean Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
BRAZIL
TABLE 85: Bipolar Disorder Market in Brazil by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 86: Brazilian Bipolar Disorder Historic Market Scenario in US$ Million by Drug Class: 2009-2017
TABLE 87: Brazilian Bipolar Disorder Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
MEXICO
TABLE 88: Bipolar Disorder Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
TABLE 89: Mexican Bipolar Disorder Historic Market Analysis in US$ Million by Drug Class: 2009-2017
TABLE 90: Mexican Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
TABLE 91: Rest of Latin America Bipolar Disorder Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
TABLE 92: Bipolar Disorder Market in Rest of Latin America by Drug Class: A Historic Review in US$ Million for 2009-2017
TABLE 93: Rest of Latin America Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
MIDDLE EAST
TABLE 94: The Middle East Bipolar Disorder Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 95: Bipolar Disorder Market in the Middle East by Region/Country in US$ Million: 2009-2017
TABLE 96: The Middle East Bipolar Disorder Market Share Breakdown by Region/Country: 2009, 2019, and 2025
TABLE 97: The Middle East Bipolar Disorder Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
TABLE 98: The Middle East Bipolar Disorder Historic Market by Drug Class in US$ Million: 2009-2017
TABLE 99: Bipolar Disorder Market in the Middle East: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
IRAN
TABLE 100: Iranian Market for Bipolar Disorder: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
TABLE 101: Bipolar Disorder Market in Iran: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
TABLE 102: Iranian Bipolar Disorder Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
ISRAEL
TABLE 103: Israeli Bipolar Disorder Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
TABLE 104: Bipolar Disorder Market in Israel in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
TABLE 105: Israeli Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
SAUDI ARABIA
TABLE 106: Saudi Arabian Bipolar Disorder Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
TABLE 107: Bipolar Disorder Historic Market Analysis in Saudi Arabia in US$ Million by Drug Class: 2009-2017
TABLE 108: Saudi Arabian Bipolar Disorder Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED ARAB EMIRATES
TABLE 109: Bipolar Disorder Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
TABLE 110: United Arab Emirates Bipolar Disorder Historic Market Analysis in US$ Million by Drug Class: 2009-2017
TABLE 111: Bipolar Disorder Market Share Distribution in United Arab Emirates by Drug Class: 2009 VS 2019 VS 2025
REST OF MIDDLE EAST
TABLE 112: Bipolar Disorder Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
TABLE 113: Rest of Middle East Bipolar Disorder Historic Market Analysis in US$ Million by Drug Class: 2009-2017
TABLE 114: Rest of Middle East Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
AFRICA
TABLE 115: African Bipolar Disorder Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
TABLE 116: Bipolar Disorder Market in Africa by Drug Class: A Historic Review in US$ Million for 2009-2017
TABLE 117: African Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
IV. COMPETITION
ABBVIE
ALLERGAN PLC
ASTRAZENECA PLC
ELI LILLY AND COMPANY
GLAXOSMITHKLINE PLC
JANSSEN PHARMACEUTICA NV
NOVARTIS INTERNATIONAL AG
OTSUKA PHARMACEUTICAL
PFIZER
V. CURATED RESEARCH

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook